Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of the enzyme telomerase, which is essential for maintaining chromosome ends (telomeres). hTERT forms the core catalytic component of the telomerase complex, working together with an RNA template subunit (telomerase RNA component, TERC). Its primary function is to add repetitive DNA sequences (TTAGGG in humans) to the ends of chromosomes, counteracting progressive shortening that occurs during DNA replication and thus preserving genomic integrity. Dysregulation or reactivation of hTERT expression enables unlimited proliferation, making it a biomarker for malignancy and an attractive target for anti-cancer therapies.
Telomerase inhibition sensitizes tumor cells to various chemotherapeutics by promoting apoptosis or limiting replicative potential; direct inhibition of transcription or enzymatic activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human Telomerase Reverse Transcriptase (hTERT).